Véronique Ducros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Véronique Ducros has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Alain Favier
4 shared publications- Charles Coudray
DMEM, INRA, Univ. Montpellier, Montpellier, France
2 shared publications François Laporte
2 shared publicationsHélène Belva-Besnet
2 shared publicationsJosiane Arnaud
Département de Biologie Intégrée, CHU de Grenoble, Grenoble F-38043, France
2 shared publicationsA. Favier
Département de biologie intégrée, CHU, BP 217, 38043 Grenoble cedex 09, France
1 shared publication
Latest Publications
- Open Access
- 25 January 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (2)
PKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal
The adrenal cortex undergoes remodeling during fetal and postnatal life. How zona reticularis emerges in the postnatal gland to support adrenarche, a process whereby higher primates increase prepubertal androgen secretion, is unknown. Using cell-fate mapping and gene deletion studies in mice, we show that activation of PKA has no effect on the fetal cortex, while it accelerates regeneration of the adult cortex, triggers zona fasciculata differentiation that is subsequently converted into a functional reticularis-like zone, and drives hypersecretion syndromes. Remarkably, PKA effects are influenced by sex. Indeed, testicular androgens increase WNT signaling that antagonizes PKA, leading to slower adrenocortical cell turnover and delayed phenotype whereas gonadectomy sensitizes males to hypercorticism and reticularis-like formation. Thus, reticularis results from ultimate centripetal conversion of adult cortex under the combined effects of PKA and cell turnover that dictate organ size. We show that PKA-induced progenitor recruitment is sexually dimorphic and may provide a paradigm for overrepresentation of women in adrenal diseases.
- 25 January 2018
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 3 (2)
Open AccessPKA signaling drives reticularis differentiation and sexually dimorphic adrenal cortex renewal
The adrenal cortex undergoes remodeling during fetal and postnatal life. How zona reticularis emerges in the postnatal gland to support adrenarche, a process whereby higher primates increase prepubertal androgen secretion, is unknown. Using cell-fate mapping and gene deletion studies in mice, we show that activation of PKA has no effect on the fetal cortex, while it accelerates regeneration of the adult cortex, triggers zona fasciculata differentiation that is subsequently converted into a functional reticularis-like zone, and drives hypersecretion syndromes. Remarkably, PKA effects are influenced by sex. Indeed, testicular androgens increase WNT signaling that antagonizes PKA, leading to slower adrenocortical cell turnover and delayed phenotype whereas gonadectomy sensitizes males to hypercorticism and reticularis-like formation. Thus, reticularis results from ultimate centripetal conversion of adult cortex under the combined effects of PKA and cell turnover that dictate organ size. We show that PKA-induced progenitor recruitment is sexually dimorphic and may provide a paradigm for overrepresentation of women in adrenal diseases.
- 1 July 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 447, 8-15
Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS
- 1 July 2015
- Published by Elsevier in Clinica Chimica Acta
- Vol. 447, 8-15
Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS
- 1 May 2015
- Published by Elsevier in Journal of Chromatography B
- Vol. 989, 54-61
Four years of LC–MS/MS method for quantification of 25-hydroxyvitamin D (D2+D3) for clinical practice
- 1 May 2015
- Published by Elsevier in Journal of Chromatography B
- Vol. 989, 54-61
Four years of LC–MS/MS method for quantification of 25-hydroxyvitamin D (D2+D3) for clinical practice
- 1 June 2010
- Published by Elsevier in Analytical Biochemistry
- Vol. 401 (1) , 7-14
Quantitative determination of plasma vitamin K1 by high-performance liquid chromatography coupled to isotope dilution tandem mass spectrometry
- 1 June 2010
- Published by Elsevier in Analytical Biochemistry
- Vol. 401 (1) , 7-14
Quantitative determination of plasma vitamin K1 by high-performance liquid chromatography coupled to isotope dilution tandem mass spectrometry
- 1 July 2009
- Published by Elsevier in Analytical Biochemistry
- Vol. 390 (1) , 46-51
Determination of dansylated polyamines in red blood cells by liquid chromatography–tandem mass spectrometry
- 1 July 2009
- Published by Elsevier in Analytical Biochemistry
- Vol. 390 (1) , 46-51
Determination of dansylated polyamines in red blood cells by liquid chromatography–tandem mass spectrometry
- 31 January 2009
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 23 (1) , 15-20
Zinc supplementation does not alter plasma homocysteine, vitamin B12 and red blood cell folate concentrations in French elderly subjects
- 31 January 2009
- Published by Elsevier in Journal of Trace Elements in Medicine and Biology
- Vol. 23 (1) , 15-20
Zinc supplementation does not alter plasma homocysteine, vitamin B12 and red blood cell folate concentrations in French elderly subjects
- Open Access
- 25 September 2008
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 15 (5) , 517-522
Should Plasma Homocysteine Be Used as a Biomarker of Venous Thromboembolism? A Case—Control Study
Mild or moderate hyperhomocysteinemia as a risk factor for venous thrombosis is still a matter of debate. The strength of this study is to bring a body of elements to evaluate whether hyperhomocysteinemia should be used as a biomarker for venous thromboembolism (VTE). These elements consist of a biological evaluation of several hematological risk factors, and an original control group made of patients with a negative Doppler ultrasonography. A total of 151 cases and 155 controls were included. Total plasma homocysteine level, MTHFR C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined. A total of 41 (27.2 %) of cases and only 9 (5.8%) of controls had at least one of the coagulation defects studied. No significant difference was observed for total homocysteine levels between the 2 groups: median (interquartile range) = 8.3 (7.2-10.8) μmol/L for cases and 8.4 (7-10.9) μmol/L for controls. We found significantly more plasma folates and/or cobalamin deficiencies in controls (18.3%) than in cases (8.6%). After adjustment for several variables significantly related to risk factors of VTE, hyperhomocysteinemia (>" xbd="2200" xhg="2176" ybd="1302" yhg="1257"/>13.2 μmol/L) was not found statistically associated with VTE: odds ratio 1.36 (95% confidence interval, 0.52-3.54). The prevalence of the homozygous 677TT polymorphism in the MTHFR gene was not increased in cases compared with controls. Mild or moderate hyperhomocysteinemia does not seem to be a strong determinant in VTE not only when the control group does not exclusively include healthy persons but also in investigated disease-free (thromboembolic disease) controls.
- 25 September 2008
- Published by SAGE Publications in Clinical and Applied Thrombosis/Hemostasis
- Vol. 15 (5) , 517-522
Open AccessShould Plasma Homocysteine Be Used as a Biomarker of Venous Thromboembolism? A Case—Control Study
Mild or moderate hyperhomocysteinemia as a risk factor for venous thrombosis is still a matter of debate. The strength of this study is to bring a body of elements to evaluate whether hyperhomocysteinemia should be used as a biomarker for venous thromboembolism (VTE). These elements consist of a biological evaluation of several hematological risk factors, and an original control group made of patients with a negative Doppler ultrasonography. A total of 151 cases and 155 controls were included. Total plasma homocysteine level, MTHFR C677T polymorphism, inherited abnormalities of the natural anticoagulant system as well as plasma folate and cobalamin levels were determined. A total of 41 (27.2 %) of cases and only 9 (5.8%) of controls had at least one of the coagulation defects studied. No significant difference was observed for total homocysteine levels between the 2 groups: median (interquartile range) = 8.3 (7.2-10.8) μmol/L for cases and 8.4 (7-10.9) μmol/L for controls. We found significantly more plasma folates and/or cobalamin deficiencies in controls (18.3%) than in cases (8.6%). After adjustment for several variables significantly related to risk factors of VTE, hyperhomocysteinemia (>" xbd="2200" xhg="2176" ybd="1302" yhg="1257"/>13.2 μmol/L) was not found statistically associated with VTE: odds ratio 1.36 (95% confidence interval, 0.52-3.54). The prevalence of the homozygous 677TT polymorphism in the MTHFR gene was not increased in cases compared with controls. Mild or moderate hyperhomocysteinemia does not seem to be a strong determinant in VTE not only when the control group does not exclusively include healthy persons but also in investigated disease-free (thromboembolic disease) controls.
- 1 February 2006
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 27 (2) , 140-143
Hyperhomocystéinémie sévère révélant une homocystinurie chez deux jeunes adultes présentant un phénotype peu marqué
- 1 February 2006
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 27 (2) , 140-143
Hyperhomocystéinémie sévère révélant une homocystinurie chez deux jeunes adultes présentant un phénotype peu marqué
- 1 January 2006
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 44 (8) , 987-990
A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice
Clin Chem Lab Med 2006;44:987–90.
- 1 January 2006
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 44 (8) , 987-990
A robust liquid chromatography tandem mass spectrometry method for total plasma homocysteine determination in clinical practice
Clin Chem Lab Med 2006;44:987–90.
- 1 February 2005
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 24 (1) , 30-37
Influence of Short-Chain Fructo-Oligosaccharides (sc-FOS) on Absorption of Cu, Zn, and Se in Healthy Postmenopausal Women
Objective: This study was carried out to evaluate the effect of short-chain fructooligosaccharides (sc-FOS) on the absorption of Cu, Zn, and Se among postmenopausal women who are potential candidates to subclinical trace element deficiencies. Design: A randomized double blind cross-over study. Setting: This study was carried out at the Human Nutrition Research Center, Clermont-Ferrand, France. Subjects: 11 postmenopausal women aged 53–70 y, not taking hormone replacement therapy were enrolled and completed the study. Interventions: Diets with 10 g/day sc-FOS or placebo were given for 5 weeks each in random order followed by a wash-out period of at least 3 weeks. At the end of each period, stable isotopes (3.19 mg 67Zn as ZnCl2, 2.06 mg 65Cu as CuCl2 and 52.3 μg 74Se as sodium selenite) and radiopaque pellets (as fecal excretion index) were administered during lunch. Stools were collected for the next 5–7 days. Isotopes were determined by ICP-MS (Cu and Zn) or GC-MS (Se). Results: Copper absorption was significantly enhanced (p = 0.042) by sc-FOS. No effect of sc-FOS was observed on Zn, and Se absorption. Conclusion: To our knowledge, this is the first study on the influence of sc-FOS on trace element metabolism. The observed increase in copper absorption may be of interest regarding daily copper requirements in menopausal women. However, the relevance of this observation remains to be established.
- 1 February 2005
- Published by Taylor & Francis in Journal of the American College of Nutrition
- Vol. 24 (1) , 30-37
Influence of Short-Chain Fructo-Oligosaccharides (sc-FOS) on Absorption of Cu, Zn, and Se in Healthy Postmenopausal Women
Objective: This study was carried out to evaluate the effect of short-chain fructooligosaccharides (sc-FOS) on the absorption of Cu, Zn, and Se among postmenopausal women who are potential candidates to subclinical trace element deficiencies. Design: A randomized double blind cross-over study. Setting: This study was carried out at the Human Nutrition Research Center, Clermont-Ferrand, France. Subjects: 11 postmenopausal women aged 53–70 y, not taking hormone replacement therapy were enrolled and completed the study. Interventions: Diets with 10 g/day sc-FOS or placebo were given for 5 weeks each in random order followed by a wash-out period of at least 3 weeks. At the end of each period, stable isotopes (3.19 mg 67Zn as ZnCl2, 2.06 mg 65Cu as CuCl2 and 52.3 μg 74Se as sodium selenite) and radiopaque pellets (as fecal excretion index) were administered during lunch. Stools were collected for the next 5–7 days. Isotopes were determined by ICP-MS (Cu and Zn) or GC-MS (Se). Results: Copper absorption was significantly enhanced (p = 0.042) by sc-FOS. No effect of sc-FOS was observed on Zn, and Se absorption. Conclusion: To our knowledge, this is the first study on the influence of sc-FOS on trace element metabolism. The observed increase in copper absorption may be of interest regarding daily copper requirements in menopausal women. However, the relevance of this observation remains to be established.